Literature DB >> 8011183

Harmonisation in pharmacovigilance.

I R Edwards1, C Biriell.   

Abstract

Mesh：

Year:  1994        PMID： 8011183     DOI： 10.2165/00002018-199410020-00001

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  3 in total

1.  Review of company postmarketing surveillance studies.

Authors:  P C Waller; S M Wood; M J Langman; A M Breckenridge; M D Rawlins
Journal:  BMJ       Date:  1992-06-06

2.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

3.  Failed or misleading adjustment for confounding.

Authors:  D A Leon
Journal:  Lancet       Date:  1993-08-21       Impact factor: 79.321
  3 in total
  96 in total

1.  A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database.

Authors:  M Lindquist; M Ståhl; A Bate; I R Edwards; R H Meyboom
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 2.  The value of reporting therapeutic ineffectiveness as an adverse drug reaction.

Authors:  R H Meyboom; M Lindquist; A K Flygare; C Biriell; I R Edwards
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

3.  An ABC of drug-related problems.

Authors:  R H Meyboom; M Lindquist; A C Egberts
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

4.  A data mining approach for signal detection and analysis.

Authors:  Andrew Bate; Marie Lindquist; I Ralph Edwards; Roland Orre
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Assessing the impact of drug safety signals from the WHO database presented in 'SIGNAL': results from a questionnaire of National pharmacovigilance Centres.

Authors:  Malin Ståhl; I Ralph Edwards; Geoffrey Bowring; Anne Kiuru; Marie Lindquist
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.

Authors:  Desireé L Kunac; Michael V Tatley
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

7.  Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.

Authors:  Mira Harrison-Woolrych; Janelle Ashton
Journal:  Drug Saf       Date:  2011-09-01       Impact factor: 5.606

8.  Arginine is preferred to glucagon for stimulation testing of β-cell function.

Authors:  R Paul Robertson; Ralph H Raymond; Douglas S Lee; Roberto A Calle; Atalanta Ghosh; Peter J Savage; Sudha S Shankar; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-26       Impact factor: 4.310

Review 9.  Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?

Authors:  David W J Clark; Johanna Strandell
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

10.  Sudden and unexpected deaths after the administration of hexavalent vaccines (diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, Haemophilius influenzae type b): is there a signal?

Authors:  Rüdiger von Kries; André Michael Toschke; Klaus Strassburger; Michael Kundi; Helen Kalies; Uta Nennstiel; Gerhard Jorch; Joachim Rosenbauer; Guido Giani
Journal:  Eur J Pediatr       Date:  2004-12-16       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.